Improving HPC Inventory Management - Considerations Regarding Consent and Discard of Cryopreserved HPC Products (24EL-402)

Please note: AABB reserves the right to make updates to this program.

Wednesday, January 17, 2024 - On-Demand Available

Program Number: 24EL-402

  • Educational Track: Quality Education
  • Topic: Biotherapies
  • Intended Audience: Directors, Laboratory Staff, Managers/Supervisors, Medical Directors
  • Teaching Level: Intermediate
  • Director: Melissa Marlowe, CHS, MBA, Vice President, Clinical Services Administration, Vitalant, Phoenix, AZ
    Moderator: Christina Celluzzi, PhD, MS, CABP(H), Director, Biotherapies, AABB, Bethesda, MD
    Speaker: Melissa Marlowe, CHS, MBA, Vice President, Clinical Services Administration, Vitalant, Phoenix, AZ

  • Program Description

    This program will address challenges that labs face related to the long-term storage of cryopreserved products and inventory management. Examples of consent documents will be discussed and how expectations for length of storage has changed over the past 10-15 years. Case studies will be used to demonstrate challenging situations that the lab/storage program may face and options to consider while evaluating a product for discard.

    Learning Objectives

    After participating in this educational activity, participants should be able to:

    • Identify key elements of a strong consent document.
    • List common challenges faced by Cellular Therapy storage programs when evaluating products for discard.
    • Describe how changing clinical and industry expectations impact storage terms and approval for discard.


    Please note: if you registered for the live eCast you do not need to register for the on-demand eCast (access to the on-demand eCast was included with the live eCast registration).

    Single ViewerRegister
    Group ViewingRegister

    Continuing Education Credit

    This activity is eligible for one (1) continuing education credit/contact hour for Physicians, Nurses (including California-based nursing professionals through CBRN), California Lab Personnel, Florida Lab Personnel and General Participation credit. AABB reserves the right to reduce or increase the number of credits granted based on the final activity duration. For more information on each credit type please visit our Continuing Education Credits webpage.

    There is no financial support for this activity.

    Jointly Accredited Provider

    In support of improving patient care, this activity has been planned and implemented by the Association for the Advancement of Blood & Biotherapies (AABB) and CME Outfitters, LLC. CME Outfitters LLC. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Physicians (ACCME): CME Outfitters, LLC, designates this live activity for a maximum of one (1) AMA PRA Category 1 CreditTM. CME Outfitters, LLC, designates this enduring activity for a maximum of one (1) AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Claiming Credit
    Live Activity - Upon completion of the live activity, you will receive instructions to complete your evaluation, which is necessary to claim credit and receive your certificate of attendance/completion (credit must be claimed by the date provided in the instructions). The evaluation can be found by logging into the AABB Education Platform.

    Enduring Activity - Once the enduring (on-demand) program is available, you will receive instructions to access the AABB Education Platform. Upon completion of viewing the enduring activity, you will need to complete the evaluation, which is necessary to claim credit and receive your certificate of completion (credit must be claimed by the date provided in the AABB Education Platform).

    Program & Credit Expiration Dates:

    • Live Activity Program Date: January 17, 2024; Credit Expiration Date: February 17, 2024
    • Enduring Activity Program Dates: January 17, 2024 – January 16, 2027; Credit Expiration Date: January 16, 2027

    Disclosure Declaration

    It is the policy of CME Outfitters, LLC, and the Association for the Advancement of Blood & Biotherapies to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that the presence of such relationships will have a negative impact on the presentations.

    Disclosures for the planners of this event can be found here. Disclosures for the program faculty, peer reviewers, and CME Outfitters, LLC. personnel are provided at the beginning of the program.

    Faculty Biographies

    Dr. Christina Celluzzi has a background in biomedical research which includes basic and applied research in cellular therapy (CT). She holds BS and MS degrees in Microbiology and earned her PhD in Medical Sciences at the University of Nijmegen in The Netherlands where she studied malarial immunity. Her entry into cellular therapies began with seminal research at the University of Pittsburgh investigating the role of dendritic cells (DC) in cytotoxic T-lymphocyte induction in melanoma. She continued in CT with the development of DC closed-culture systems and supporting assays for clinical application as research scientist and faculty member at the American Red Cross Holland Biomedical Laboratory and University of Maryland School of Medicine. She applies her more than 30 years of experience to her current position at AABB serving as a resource to its many CT professionals – helping to create and develop projects, including the Cellular Therapies Certificate Program, as well as other activities for the biotherapies professional.

    Melissa MarloweMelissa Marlowe is the Vice President of Clinical Services Administration at Vitalant, over-seeing the HLA and Cellular Therapy laboratories. She has worked in clinical laboratories (HLA & Cellular Therapy) and transplantation support (Bone Marrow/HPCs and solid organ) for over 25 years. She started in the field as an HLA Laboratory Technician, moving to Lab Supervisor and then HLA Lab Manager. She expanded her support of HPC transplantation in 2013 with a move to Director, overseeing the HLA and Cellular Therapy Labs. She holds a Bachelor of Science in Molecular & Cellular Biology from the University of Arizona and a Bachelor of Science in Clinical Laboratory Sciences from Arizona State University. Melissa is a Certified Medical Technologist and a Certified Histocompatibility Specialist (CHS) through the American Board of Histocompatibility and Immunology. She earned her MBA from the University of Arizona Eller College of Management.